INFECTIOUS AGENTS AND VACCINES IN ADULTS AND CHILDREN
Project NumberN01AO062712-006
Contact PI/Project LeaderCLEMENTS, MARY L
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
The purpose of this contract is to understand the pathogenesis of
important respiratory and enteric viral pathogens of humans and to develop
means to prevent illness caused by these viruses. Johns Hopkins
University will provide volunteers and a facility in which to study the
biology of medically important viruses in humans, to examine the hosts'
immune response to these viruses and to test new candidate live virus
vaccines for safety, genetic stability, immunogenicity, transmissibility
and protective efficacy Studies will also include administration of wild
type viruses to volunteers in order to assess virulence. Subsequently,
these wild viruses will be used to challenge vaccinated volunteers in
order to assess the extent of immunity induced by candidate vaccines.
Studies with vaccines will include an evaluation of their safety,
immunogenicity, transmissibility, and protective safety.
These studies will include both adult and pediatric subjects since the
viruses studied cause disease in both these populations; e.g., influenza
A viruses causes severe respiratory disease in the elderly and,
conversely, respiratory syncytial virus causes severe respiratory disease
in infants. In summary, this contract will provide both the facility and
volunteers, (adult and pediatric populations) to study the biology and
immunology of a variety of viral pathogens and will serve as a testing
center for the development of new vaccines effective against these agents.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
16-January-1996
Project End Date
15-January-2001
Budget Start Date
26-September-1997
Budget End Date
31-August-1999
Project Funding Information for 1997
Total Funding
$1,683,117
Direct Costs
Indirect Costs
$437,610
Year
Funding IC
FY Total Cost by IC
1997
National Institute of Allergy and Infectious Diseases
$1,683,117
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for N01AO062712-006
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for N01AO062712-006
Patents
No Patents information available for N01AO062712-006
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for N01AO062712-006
Clinical Studies
No Clinical Studies information available for N01AO062712-006
News and More
Related News Releases
No news release information available for N01AO062712-006
History
No Historical information available for N01AO062712-006
Similar Projects
No Similar Projects information available for N01AO062712-006